Related Experiment Video
Updated: May 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mitotic Kinases and p53 Signaling
Geun-Hyoung Ha1, Eun-Kyoung Yim Breuer
1Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
Abstract:
Mitosis is tightly regulated and any errors in this process often lead to aneuploidy, genomic instability, and tumorigenesis. Deregulation of mitotic kinases is significantly associated with improper cell division and aneuploidy. Because of their importance during mitosis and the relevance to cancer, mitotic kinase signaling has been extensively studied over the past few decades and, as a result, several mitotic kinase inhibitors have been developed. Despite promising preclinical results, targeting mitotic kinases for cancer therapy faces numerous challenges, including safety and patient selection issues. Therefore, there is an urgent need to better understand the molecular mechanisms underlying mitotic kinase signaling and its interactive network. Increasing evidence suggests that tumor suppressor p53 functions at the center of the mitotic kinase signaling network. In response to mitotic spindle damage, multiple mitotic kinases phosphorylate p53 to either activate or deactivate p53-mediated signaling. p53 can also regulate the expression and function of mitotic kinases, suggesting the existence of a network of mutual regulation, which can be positive or negative, between mitotic kinases and p53 signaling. Therefore, deciphering this regulatory network will provide knowledge to overcome current limitations of targeting mitotic kinases and further improve the results of targeted therapy.
Insights
Errors in mitosis, crucial for cell division, can cause cancer. Understanding the network between mitotic kinases and p53 signaling is key to improving cancer therapies targeting these pathways.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Therapeutics
Background:
- Mitosis is a tightly regulated process; errors lead to aneuploidy, genomic instability, and cancer.
- Mitotic kinase deregulation is linked to cell division errors and aneuploidy, making them cancer targets.
- Current mitotic kinase inhibitors face challenges in safety and patient selection for cancer therapy.
Purpose of the Study:
- To explore the molecular mechanisms of mitotic kinase signaling and its interactive network.
- To investigate the central role of tumor suppressor p53 within the mitotic kinase signaling network.
- To provide insights for overcoming limitations in targeting mitotic kinases for improved cancer treatment outcomes.
Main Methods:
- Literature review and analysis of existing research on mitotic kinase signaling pathways.
- Examination of the interplay between mitotic kinases and p53 in response to mitotic spindle damage.
- Exploration of mutual regulatory mechanisms between mitotic kinases and p53 signaling.
Main Results:
- Mitotic kinase signaling is crucial for proper cell division; its deregulation contributes to aneuploidy and tumorigenesis.
- Tumor suppressor p53 is centrally positioned in the mitotic kinase signaling network.
- Evidence indicates a mutual regulatory network between mitotic kinases and p53 signaling, involving phosphorylation and gene expression modulation.
Conclusions:
- Deciphering the regulatory network between mitotic kinases and p53 is essential for advancing cancer therapy.
- Understanding this network can help overcome safety and patient selection issues associated with current mitotic kinase inhibitors.
- Targeting the mitotic kinase-p53 network holds promise for improving the efficacy of cancer treatments.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

